27 June 2025 -- Ravensburg, Germany and Illinois, US -- Vetter, a leading, globally operating Contract Development and Manufacturing Organization (CDMO), celebrated the start of construction for its new clinical manufacturing site in Des Plaines with an official groundbreaking ceremony on June 26.

26 June 2025 -- Virginia, US -- AAPS is excited to announce the opening and closing plenary speakers for the 2025 PharmSci 360, taking place November 9-12, in San Antonio, Texas.

24 June 2025 -- Cambridge, UK -- Enhanc3d Genomics, the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge.

24 June 2025 -- Lausanne, Switzerland and Maryland, US -- Alithea Genomics, a pioneering biotech company based in Switzerland and the USA specializing in high-throughput RNA sequencing solutions, today announced the commercial launch of MERCURIUS™ FLASH-seq, a next-generation library preparation kit for full-length single-cell RNA sequencing.

24 June 2025 -- Cambridge, UK -- OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced it has secured £1.8M in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.

19 June 2025 -- Hamburg, Germany and Oss, The Netherlands -- Flindr Therapeutics, a precision oncology company developing first-in-class small molecule inhibitors for cancer, and CrystalsFirst, a leader in structure-based drug discovery and target enablement, today announced a strategic partnership to accelerate target enablement and drug discovery across Flindr’s oncology pipeline.

16 June 2025 -- Minnesota, US -- Ecolab Life Sciences today announced it has launched an innovative new resin to help achieve cost savings and optimize operations throughout the antibody manufacturing process.

18 June 2025 -- Oxford, UK -- Refeyn, the company behind pioneering mass photometry technology, announces that mass photometry has been recognized by the U.S. Pharmacopeia (USP)—and referenced in the new draft USP general chapter <1067>—as a key orthogonal method for characterizing USP’s new adeno-associated virus (AAV) reference standards.

17 June 2025 -- Cambridge, UK and Massachusetts, US -- Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve cancer outcomes for at-risk patients, today announced the commercial launch of its AI Precision Medicine Platform, alongside a pre-print¹ reporting the first validated method for isolating hepatocyte EVs from plasma for organ-specific proteomic and miRNA profiling.

16 June 2025 -- California, US -- Biotium, a leading provider of innovative fluorescent technologies for life science research, announces the release of the Glo-Plate™ White Photoactivation Device. This is a compact, LED-powered light box designed to develop DNA gels stained with DNAzure® Blue Nucleic Acid Gel Stain.

12 June 2025 -- London, UK -- Data stands at the centre of transformation in today’s digital labs — both as a major obstacle and a driving force for innovation, according to a survey of more than 150 scientists from Titian Software and Labguru.

12 June 2025 -- Montpellier, France and Montreal, Canada -- Oxeltis, a Contract Research Organization (CRO), and Molecular Forecaster Inc. (MFI), a computational chemistry company, today announce their strategic partnership, leveraging the strengths of both organizations to offer the seamless integration of in silico design with high-quality chemical synthesis.